-+ 0.00%
-+ 0.00%
-+ 0.00%
BridgeBio Oncology Therapeutics President and CEO Pedro Beltran Sells $3,442.67 in Common Shares
Share
Listen to the news
BridgeBio Oncology Therapeutics President and CEO Pedro Beltran Sells $3,442.67 in Common Shares
  • BridgeBio Oncology Therapeutics President and CEO Pedro Beltran sold 1,870 shares of Common Stock on Nov. 18, 2026.
  • The reported sale price was $1.841 per share, leaving Beltran with 41,659 shares held directly.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bridgebio Oncology Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-470272), on November 20, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending